There is power in unity. With HEMEO’s AI-based clinical decision support applications, you get the power to personalise prevention and treatment of coagulation complications. By consolidating data from multiple sources in a form that doctors can act on early and with confidence – this has the power to reduce excess morbidity and death. Hemeo’s technology has the potential to improve patients’ recovery process and survival rate, even while significantly saving costs.
– Dr Andrew Klein
Chair of Department of Anesthesia and Intensive Care
Royal Papworth NHS, Cambridge University,
UK Editor-in-Chief of Anesthesia
Predicting coagulation risks will transform the management of bleeding and thrombosis and allow personalised treatments. Acting quickly on patient specific insights provided by HEMEO, doctors may significantly reduce the need for blood transfusions, and therefore improve these patients’ survival rates.
To stay up to date on our latest developments, simply fill in your email address below.